These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25723899)

  • 1. The structural biology of CRISPR-Cas systems.
    Jiang F; Doudna JA
    Curr Opin Struct Biol; 2015 Feb; 30():100-111. PubMed ID: 25723899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex.
    Guo TW; Bartesaghi A; Yang H; Falconieri V; Rao P; Merk A; Eng ET; Raczkowski AM; Fox T; Earl LA; Patel DJ; Subramaniam S
    Cell; 2017 Oct; 171(2):414-426.e12. PubMed ID: 28985564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CasX enzymes comprise a distinct family of RNA-guided genome editors.
    Liu JJ; Orlova N; Oakes BL; Ma E; Spinner HB; Baney KLM; Chuck J; Tan D; Knott GJ; Harrington LB; Al-Shayeb B; Wagner A; Brötzmann J; Staahl BT; Taylor KL; Desmarais J; Nogales E; Doudna JA
    Nature; 2019 Feb; 566(7743):218-223. PubMed ID: 30718774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
    Xiao Y; Ng S; Nam KH; Ke A
    Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.
    Mohanraju P; Makarova KS; Zetsche B; Zhang F; Koonin EV; van der Oost J
    Science; 2016 Aug; 353(6299):aad5147. PubMed ID: 27493190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural biology. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target.
    Mulepati S; Héroux A; Bailey S
    Science; 2014 Sep; 345(6203):1479-84. PubMed ID: 25123481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli.
    Zhao H; Sheng G; Wang J; Wang M; Bunkoczi G; Gong W; Wei Z; Wang Y
    Nature; 2014 Nov; 515(7525):147-50. PubMed ID: 25118175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system.
    Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL
    Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas: Adapting to change.
    Jackson SA; McKenzie RE; Fagerlund RD; Kieper SN; Fineran PC; Brouns SJ
    Science; 2017 Apr; 356(6333):. PubMed ID: 28385959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural biology. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli.
    Jackson RN; Golden SM; van Erp PB; Carter J; Westra ER; Brouns SJ; van der Oost J; Terwilliger TC; Read RJ; Wiedenheft B
    Science; 2014 Sep; 345(6203):1473-9. PubMed ID: 25103409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.
    Liu TY; Doudna JA
    J Biol Chem; 2020 Oct; 295(42):14473-14487. PubMed ID: 32817336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural organization of a Type III-A CRISPR effector subcomplex determined by X-ray crystallography and cryo-EM.
    Dorsey BW; Huang L; Mondragón A
    Nucleic Acids Res; 2019 Apr; 47(7):3765-3783. PubMed ID: 30759237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New CRISPR-Cas systems from uncultivated microbes.
    Burstein D; Harrington LB; Strutt SC; Probst AJ; Anantharaman K; Thomas BC; Doudna JA; Banfield JF
    Nature; 2017 Feb; 542(7640):237-241. PubMed ID: 28005056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes.
    Plagens A; Richter H; Charpentier E; Randau L
    FEMS Microbiol Rev; 2015 May; 39(3):442-63. PubMed ID: 25934119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular organization of the type II-A CRISPR adaptation module and its interaction with Cas9 via Csn2.
    Ka D; Jang DM; Han BW; Bae E
    Nucleic Acids Res; 2018 Oct; 46(18):9805-9815. PubMed ID: 30102386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Molecule Insight Into Target Recognition by CRISPR-Cas Complexes.
    Rutkauskas M; Krivoy A; Szczelkun MD; Rouillon C; Seidel R
    Methods Enzymol; 2017; 582():239-273. PubMed ID: 28062037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and evolution of type II CRISPR-Cas systems.
    Chylinski K; Makarova KS; Charpentier E; Koonin EV
    Nucleic Acids Res; 2014 Jun; 42(10):6091-105. PubMed ID: 24728998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures of the CRISPR genome integration complex.
    Wright AV; Liu JJ; Knott GJ; Doxzen KW; Nogales E; Doudna JA
    Science; 2017 Sep; 357(6356):1113-1118. PubMed ID: 28729350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas adaptation in Escherichia coli.
    Mitić D; Bolt EL; Ivančić-Baće I
    Biosci Rep; 2023 Mar; 43(3):. PubMed ID: 36809461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.